Therigy partners with EPI-W to expand research on specialty pharmacy outcomes

Therigy noted that EPI-Q brings more than 20 years of experience to the research table.
Therigy noted that EPI-Q brings more than 20 years of experience to the research table. | Contributed image

Therigy, a company that pioneered patient-focused specialty therapy management, recently announced a strategic partnership with EPI-Q Inc. to expand research on specialty pharmacy outcomes.

“As the specialty pharmacy industry and the health care industry as a whole continue to make the revolutionary shift from volume-based to value-based care, real-world evidence becomes increasingly important for ensuring positive patient outcomes and shaping the future of the industry,” Therigy said in a statement.

Therigy noted that EPI-Q brings more than 20 years of experience to the research table, along with a full team of epidemiologists and research scientists, health policy analysts, and clinicians. Together, the companies will investigate specialty pharmacy drugs in real-world settings by examining their utilization, effectiveness, and clinical outcomes.

“Therigy’s comprehensive data, coupled with EPI-Q’s dedication to scientific research and analysis, will open doors for pharmacies, manufacturers, hospital systems, payers, and patients alike,” Dr. Russel Allinson, Therigy’s CEO and chief clinical officer, said in a statement. “This partnership will facilitate further insights into how critical drugs are performing, and how this research can be applied to improving specialty pharmacy patient outcomes over the long term.”

Want to get notified whenever we write about Solutions Specialty Pharmacy ?
Next time we write about Solutions Specialty Pharmacy, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Solutions Specialty Pharmacy 8579 S. Eastern Ave., Suite B Las Vegas, Nev. - 89123